Status | Study |
Completed |
Study Name: The Effect of Erigeron Injection on Acute Cerebral Infarction Serum VEGF, MMP-9 and EPC Levels Condition: Cerebral Infarction Date: 2013-08-19 Interventions: Drug: Erigeron Injection Erige |
Completed |
Study Name: Identification the Cause of Silent Cerebral infarctiON in Healthy Subjects (ICONS) Condition: Cerebral Infarction Date: 2011-09-06 |
Completed |
Study Name: Chinese Assessment for Vinpocetine In Neurology Condition: Cerebral Infarction Date: 2011-07-19 |
Completed |
Study Name: Treating Apoplectic Sequela With Acupuncture: a Randomized Controlled Study Condition: Cerebral Infarction Date: 2009-10-27 Interventions: Other: acupuncture Xing Nao Ka |
Completed |
Study Name: Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject Condition: Atherosclerosis Cerebral Infarction Date: 2009-01-15 Interventions: Drug: Cilostazol group Cilosta |
Completed |
Study Name: Action of Amantadine on Post-Stroke Aphasic Patients Condition: Cerebral Infarction Date: 2009-01-09 Interventions: Drug: Amantadin Amantadin caps |
Completed |
Study Name: Cilostazol Stroke Prevention Study : A Placebo-Controlled Double-Blind Trial for Secondary Prevention of Cerebral Infarction. Condition: Cerebral Infarction Date: 2008-10-02 Interventions: Drug: cilostazol oral tablet 1 |
Completed |
Study Name: Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005; MK-5348-017) Condition: Cerebral Infarction Date: 2008-05-22 Interventions: Drug: Vorapaxar 2.5 mg Oral ta |
Completed |
Study Name: Surgical Manipulation of the Aorta and Cerebral Infarction Condition: Coronary Heart Disease Stroke Cerebr Date: 2007-11-14 Interventions: Procedure: OBCAB (Off Pump Coronary Artery Bypass Grafting) |
Completed |
Study Name: Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment Condition: Cerebral Infarction Date: 2006-10-10 Interventions: Drug: clopidogrel (SR25990C) oral administration |